Literature DB >> 7200279

Akabane disease in cattle: congenital abnormalities caused by viral infection. Experimental disease.

S Konno, M Nakagawa.   

Abstract

Nonpurulent encephalomyelitis and polymyositis were primary lesions of cattle and goats experimentally infected with Akabane virus. Two caprine fetuses, two months old, were infected placentally and examined 11 days after inoculation; twin caprine fetuses, three months old, were inoculated intramuscularly through the dam's uterus and examined nine days after inoculation. Both lesions were seen in each fetus. Reactive proliferation of immature endothelial cells was a significant encephalitic change. Myositic changes included parenchymal degeneration and cell infiltration in fetuses in the myotubule phase and the beginning of the myofiber phase. Only nonpurulent encephalomyelitis was seen in six calves 14 days to one year old, inoculated intracerebrally and examined six to 47 days after inoculation. Nerve-cell degeneration, neurological mobilization, and perivascular cuffs were typical encephalitic changes in the calves. Five fetuses were infected transplacentally and had polymyositis alone. The four bovine fetuses, two to six months old, were examined nine to 18 days after inoculation, and one caprine fetus, one month old, was examined 11 days after inoculation. Neither encephalomyelitis nor polymyositis was seen in four calves under one year old that were inoculated intravenously.

Entities:  

Mesh:

Year:  1982        PMID: 7200279     DOI: 10.1177/030098588201900305

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  8 in total

1.  Identification of the target cells and sequence of infection during experimental infection of ovine fetuses with Cache Valley virus.

Authors:  Aline Rodrigues Hoffmann; Christabel Jane Welsh; Patricia Wilcox Varner; Andres de la Concha-Bermejillo; Judith Marchand Ball; Andy Ambrus; John Francis Edwards
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

2.  A congenital defect resembling Hereford syndrome I in Alberta.

Authors:  G A Chalmers; L Rockenbach; S Marshall
Journal:  Can Vet J       Date:  1990-01       Impact factor: 1.008

3.  Characterization of a recombinant Akabane mutant virus with knockout of a nonstructural protein NSs in a pregnant goat model.

Authors:  Akiko Takenaka-Uema; Norasuthi Bangphoomi; Chieko Shioda; Kazuyuki Uchida; Fumihiro Gen; Kentaro Kato; Takeshi Haga; Shin Murakami; Hiroomi Akashi; Taisuke Hoimoto
Journal:  Virol Sin       Date:  2016-06       Impact factor: 4.327

4.  Sero-survey on Aino, Akabane, Chuzan, bovine ephemeral fever and Japanese encephalitis virus of cattle and swine in Korea.

Authors:  Seong In Lim; Chang Hee Kweon; Dong Seob Tark; Seong Hee Kim; Dong Kun Yang
Journal:  J Vet Sci       Date:  2007-03       Impact factor: 1.672

5.  Cleavage of Akabane virus S RNA in the brain of infected ruminants.

Authors:  Aviad Levin; Marisol Rubinstein-Guini; Larisa Kuznetzova; Yehuda Stram
Journal:  Virus Genes       Date:  2008-02-02       Impact factor: 2.332

6.  Immunophenotyping of inflammatory cells associated with Schmallenberg virus infection of the central nervous system of ruminants.

Authors:  Vanessa Herder; Florian Hansmann; Peter Wohlsein; Martin Peters; Mariana Varela; Massimo Palmarini; Wolfgang Baumgärtner
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

7.  Experimental infection of cows with newly isolated Akabane virus strain (AKAV-7) causing encephalomyelitis.

Authors:  Hyeyeoun Lee; Hansol Jeong; Surim Park; Myeon-Sik Yang; Jongwon Kim; Jaehyun Bae; Yonghwan Kwon; Min-Su Kim; Jae-Ku Oem; Myoung-Heon Lee; Chae-Woong Lim; Bumseok Kim
Journal:  Vet Res       Date:  2016-06-10       Impact factor: 3.683

Review 8.  Schmallenberg virus: a systematic international literature review (2011-2019) from an Irish perspective.

Authors:  Áine B Collins; Michael L Doherty; Damien J Barrett; John F Mee
Journal:  Ir Vet J       Date:  2019-10-09       Impact factor: 2.146

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.